MX345518B - Compuestos analgesicos, metodos, y formulaciones. - Google Patents
Compuestos analgesicos, metodos, y formulaciones.Info
- Publication number
- MX345518B MX345518B MX2013008708A MX2013008708A MX345518B MX 345518 B MX345518 B MX 345518B MX 2013008708 A MX2013008708 A MX 2013008708A MX 2013008708 A MX2013008708 A MX 2013008708A MX 345518 B MX345518 B MX 345518B
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- formulations
- analgesic compounds
- compounds
- analgesic
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 230000000202 analgesic effect Effects 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C215/64—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/74—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C219/26—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C219/28—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton having amino groups bound to acyclic carbon atoms of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C219/26—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C219/28—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton having amino groups bound to acyclic carbon atoms of the carbon skeleton
- C07C219/30—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton having amino groups bound to acyclic carbon atoms of the carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/14—All rings being cycloaliphatic
- C07C2602/20—All rings being cycloaliphatic the ring system containing seven carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
- C07C2602/42—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing seven carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
- C07C2602/44—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing eight carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/50—Spiro compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pain & Pain Management (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/CN2011/070706 WO2012100423A1 (en) | 2011-01-27 | 2011-01-27 | Analgesic compounds, methods, and formulations |
| PCT/US2012/021181 WO2012102875A2 (en) | 2011-01-27 | 2012-01-13 | Analgesic compounds, methods, and formulations |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2013008708A MX2013008708A (es) | 2014-01-23 |
| MX345518B true MX345518B (es) | 2017-02-02 |
Family
ID=45558412
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2013008708A MX345518B (es) | 2011-01-27 | 2012-01-13 | Compuestos analgesicos, metodos, y formulaciones. |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US8802728B2 (enExample) |
| EP (1) | EP2668152B1 (enExample) |
| JP (1) | JP6002153B2 (enExample) |
| KR (1) | KR101612168B1 (enExample) |
| CN (2) | CN105753723B (enExample) |
| AR (2) | AR084815A1 (enExample) |
| AU (1) | AU2012209430B2 (enExample) |
| BR (1) | BR112013018527B1 (enExample) |
| CA (1) | CA2825816C (enExample) |
| CL (1) | CL2013002102A1 (enExample) |
| CO (1) | CO6781505A2 (enExample) |
| EA (1) | EA024101B1 (enExample) |
| ES (1) | ES2612495T3 (enExample) |
| IL (1) | IL227250A (enExample) |
| IN (1) | IN2013MN01164A (enExample) |
| MX (1) | MX345518B (enExample) |
| MY (1) | MY163262A (enExample) |
| PH (1) | PH12013501589A1 (enExample) |
| SG (1) | SG192131A1 (enExample) |
| TW (1) | TWI564275B (enExample) |
| UA (1) | UA110122C2 (enExample) |
| WO (2) | WO2012100423A1 (enExample) |
| ZA (1) | ZA201304786B (enExample) |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1199764B (de) * | 1963-04-02 | 1965-09-02 | Gruenenthal Chemie | Verfahren zur Herstellung von basisch substituierten Phenolaethern |
| DE1518663A1 (de) * | 1965-08-02 | 1969-12-18 | Gruenenthal Chemie | Basisch substituierte Cycloalken-derivate und Verfahren zu ihrer Herstellung |
| US3652589A (en) * | 1967-07-27 | 1972-03-28 | Gruenenthal Chemie | 1-(m-substituted phenyl)-2-aminomethyl cyclohexanols |
| DE19547766A1 (de) * | 1995-12-20 | 1997-06-26 | Gruenenthal Gmbh | 1-Phenyl-2-dimethylaminomethyl-cyclohexan-1-ol-verbindungen als pharmazeutische Wirkstoffe |
| DE19805370A1 (de) * | 1997-03-14 | 1998-09-17 | Gruenenthal Gmbh | Substituierte Aminoverbindungen und ihre Verwendung als analgetisch wirksame Substanzen |
| ES2141688B1 (es) * | 1998-11-06 | 2001-02-01 | Vita Invest Sa | Nuevos esteres derivados de compuestos fenil-ciclohexil sustituidos. |
| DE10049483A1 (de) * | 2000-09-29 | 2002-05-02 | Gruenenthal Gmbh | Substituierte 1-Aminobutan-3-ol-Derivate |
| DE10049481A1 (de) * | 2000-09-29 | 2002-05-02 | Gruenenthal Gmbh | Substituierte C-Cyclohexylmethylamin-Derivate |
| AU2002364517A1 (en) | 2001-11-30 | 2003-06-17 | Sepracor Inc. | Tramadol analogs and uses thereof |
| US20050182131A1 (en) | 2002-07-19 | 2005-08-18 | Gruenenthal Gmbh | 1-Phenyl-2-dimethylaminomethyl cyclohexane compounds and therapies for depressive symptoms, pain and incontinence |
| DE10233048A1 (de) * | 2002-07-19 | 2004-01-29 | Grünenthal GmbH | Verwendung von 1-Phenyl-3dimethylamino-propanverbindungen zur Therapie von depressiven Symptomatiken |
| EP2022778A1 (en) * | 2007-08-07 | 2009-02-11 | Laboratorios del Dr. Esteve S.A. | A crystalline form of (R,R)-tramadol-(S)-naproxene salt |
-
2011
- 2011-01-27 WO PCT/CN2011/070706 patent/WO2012100423A1/en not_active Ceased
-
2012
- 2012-01-10 AR ARP120100071A patent/AR084815A1/es active IP Right Grant
- 2012-01-13 KR KR1020137022533A patent/KR101612168B1/ko active Active
- 2012-01-13 US US13/883,803 patent/US8802728B2/en active Active
- 2012-01-13 EA EA201390857A patent/EA024101B1/ru not_active IP Right Cessation
- 2012-01-13 CN CN201610195255.7A patent/CN105753723B/zh active Active
- 2012-01-13 CN CN201280006664.8A patent/CN103328433B/zh active Active
- 2012-01-13 UA UAA201308974A patent/UA110122C2/uk unknown
- 2012-01-13 SG SG2013056627A patent/SG192131A1/en unknown
- 2012-01-13 ES ES12701809.1T patent/ES2612495T3/es active Active
- 2012-01-13 EP EP12701809.1A patent/EP2668152B1/en active Active
- 2012-01-13 AU AU2012209430A patent/AU2012209430B2/en active Active
- 2012-01-13 WO PCT/US2012/021181 patent/WO2012102875A2/en not_active Ceased
- 2012-01-13 CA CA2825816A patent/CA2825816C/en active Active
- 2012-01-13 IN IN1164MUN2013 patent/IN2013MN01164A/en unknown
- 2012-01-13 MX MX2013008708A patent/MX345518B/es active IP Right Grant
- 2012-01-13 MY MYPI2013701314A patent/MY163262A/en unknown
- 2012-01-13 TW TW101101513A patent/TWI564275B/zh active
- 2012-01-13 JP JP2013551992A patent/JP6002153B2/ja active Active
- 2012-01-13 BR BR112013018527-9A patent/BR112013018527B1/pt active IP Right Grant
- 2012-01-13 PH PH1/2013/501589A patent/PH12013501589A1/en unknown
-
2013
- 2013-06-26 ZA ZA2013/04786A patent/ZA201304786B/en unknown
- 2013-06-27 IL IL227250A patent/IL227250A/en active IP Right Grant
- 2013-07-23 CL CL2013002102A patent/CL2013002102A1/es unknown
- 2013-07-26 CO CO13177731A patent/CO6781505A2/es active IP Right Grant
-
2022
- 2022-06-21 AR ARP220101618A patent/AR126189A2/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014MN02598A (enExample) | ||
| PH12015501993B1 (en) | Pyrazole-amide compound and medicinal uses therefor | |
| PH12013502112A1 (en) | Amide compound and pharmaceutical application therefor | |
| MY184306A (en) | Compounds for the treatment and prophylaxis of respiratory syncytial virus disease | |
| MY163083A (en) | Solid forms of a pharmaceutically active substance | |
| IN2015DN01119A (enExample) | ||
| MY172422A (en) | Pyrazole compound and pharmaceutical use thereof | |
| MX2014003701A (es) | Compuestos para el tratamiento y profilaxis de enfermedad por el virus sincitial respiratorio. | |
| WO2012135615A3 (en) | Enopeptins, uses thereof, and methods of synthesis thereto | |
| HK1205095A1 (en) | Methods and intermediates for preparing pharmaceutical agents | |
| IN2014DN10669A (enExample) | ||
| JO2930B1 (en) | A new process for the synthesis of ivabradine and salts of addition with a pharmaceutically acceptable acid | |
| JO2854B1 (en) | A new method for the synthesis of anfabradine and its added salts with acid is pharmaceutically acceptable. | |
| TN2015000095A1 (en) | Macrolide derivatives, preparation thereof and therapeutic use thereof | |
| UA118008C2 (uk) | Спосіб синтезу (2е)-3-(3,4-диметоксифеніл)проп-2-еннітрилу та застосування в синтезі івабрадину та його адитивних солей з фармацевтично прийнятною кислотою | |
| MY170662A (en) | New process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid | |
| MY181682A (en) | Stabilised amorphous form of agomelatine, a process for its preparation and pharmaceutical compositions containing it | |
| EA201301235A1 (ru) | Новый способ синтеза 3-(2-бром-4,5-диметоксифенил)пропаннитрила и применение в синтезе ивабрадина и его фармацевтически приемлемых кислотно-аддитивных солей | |
| IN2014DE01203A (enExample) | ||
| IN2013MN01164A (enExample) | ||
| EA201301020A1 (ru) | Новый способ синтеза 3-(2-бром-4,5-диметоксифенил)пропаннитрила и применение в синтезе ивабрадина и его фармацевтически приемлемых кислотно-аддитивных солей | |
| JO3083B1 (ar) | عملية جديدة لتخليق إيفابرادين وأملاحه المضافة مع حمض مقبول صيدلانيا | |
| EA201300281A2 (ru) | Новый способ синтеза ивабрадина и его аддитивных солей с фармацевтически приемлемой кислотой | |
| UA65175U (en) | Method of uranostaphyloplasty |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |